Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cognition and eye movements: assessment of cerebral dysfunction.
Estimating typical multiple sclerosis disability progression speed from clinical observations.
Neuromyelitis optica in pregnancy complicated by posterior reversible encephalopathy syndrome, eclampsia and fetal death.
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
Myeloid cells as target of fingolimod action in multiple sclerosis.
Early accurate diagnosis crucial in multiple sclerosis.
Remission with fingolimod in a case of demyelinating polyneuropathy.
Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
Resistance training and vibration improve muscle strength and functional capacity in female patients with multiple sclerosis.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Age and the role of restricted activities in adjustment to disability related pain.
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Beneficial effects of UV radiation other than via vitamin D production.
The harm of ham hocks: Foreign body impaction in long-standing multiple sclerosis.
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
Cognitive reserve in multiple sclerosis: Protective effects of education.
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptoms.
Chromosomal radiosensitivity in patients with multiple sclerosis.
Pages
« first
‹ previous
…
318
319
320
321
322
323
324
325
326
…
next ›
last »